Guadarrama-Escobar, O.R.; Sánchez-Vázquez, I.; Serrano-Castañeda, P.; Chamorro-Cevallos, G.A.; Rodríguez-Cruz, I.M.; Sánchez-Padrón, A.Y.; Anguiano-Almazán, E.; Peña-Juárez, M.C.; Méndez-Albores, A.; Domínguez-Delgado, C.L.;
et al. Development, Characterization, Optimization, and In Vivo Evaluation of Methacrylic Acid–Ethyl Acrylate Copolymer Nanoparticles Loaded with Glibenclamide in Diabetic Rats for Oral Administration. Pharmaceutics 2021, 13, 2023.
https://doi.org/10.3390/pharmaceutics13122023
AMA Style
Guadarrama-Escobar OR, Sánchez-Vázquez I, Serrano-Castañeda P, Chamorro-Cevallos GA, Rodríguez-Cruz IM, Sánchez-Padrón AY, Anguiano-Almazán E, Peña-Juárez MC, Méndez-Albores A, Domínguez-Delgado CL,
et al. Development, Characterization, Optimization, and In Vivo Evaluation of Methacrylic Acid–Ethyl Acrylate Copolymer Nanoparticles Loaded with Glibenclamide in Diabetic Rats for Oral Administration. Pharmaceutics. 2021; 13(12):2023.
https://doi.org/10.3390/pharmaceutics13122023
Chicago/Turabian Style
Guadarrama-Escobar, Omar Rodrigo, Ivonne Sánchez-Vázquez, Pablo Serrano-Castañeda, German Alberto Chamorro-Cevallos, Isabel Marlen Rodríguez-Cruz, Adalí Yisell Sánchez-Padrón, Ericka Anguiano-Almazán, Ma. Concepción Peña-Juárez, Abraham Méndez-Albores, Clara Luisa Domínguez-Delgado,
and et al. 2021. "Development, Characterization, Optimization, and In Vivo Evaluation of Methacrylic Acid–Ethyl Acrylate Copolymer Nanoparticles Loaded with Glibenclamide in Diabetic Rats for Oral Administration" Pharmaceutics 13, no. 12: 2023.
https://doi.org/10.3390/pharmaceutics13122023
APA Style
Guadarrama-Escobar, O. R., Sánchez-Vázquez, I., Serrano-Castañeda, P., Chamorro-Cevallos, G. A., Rodríguez-Cruz, I. M., Sánchez-Padrón, A. Y., Anguiano-Almazán, E., Peña-Juárez, M. C., Méndez-Albores, A., Domínguez-Delgado, C. L., Mercado-Márquez, C., Rodríguez-Pérez, B., & Escobar-Chávez, J. J.
(2021). Development, Characterization, Optimization, and In Vivo Evaluation of Methacrylic Acid–Ethyl Acrylate Copolymer Nanoparticles Loaded with Glibenclamide in Diabetic Rats for Oral Administration. Pharmaceutics, 13(12), 2023.
https://doi.org/10.3390/pharmaceutics13122023
